Tilak Healthcare Announces Positive Results From Its TIL002 Study Using the OdySight® App, Which Allows Patients With Retinal Diseases to Monitor Their Vision Themselves
Tilak Healthcare, a leader in the field of digital health solutions for monitoring chronic ophthalmic diseases, announces positive results from its TIL002 clinical trial aimed at validating the OdySight® mobile app as a tool allowing patients to measure their visual acuity at home by themselves.